Literature DB >> 7007210

Variation in the susceptibility of bovine mycoplasmas to killing by the alternative complement pathway in bovine serum.

C J Howard.   

Abstract

All but one of nine Acholeplasma strains were susceptible to killing by gnotobiotic-calf serum while all but one of fifteen Mycoplasma strains were resistant. The mechanism of killing was examined using inhibitors of complement, viz. EDTA. MgEGTA. epsilon-amino caproic acid, and also by desalting serum and adding MgCl2 and CaCl2. The results indicated that, when strains were killed by serum from gnotobiotic calves it was by the alternative complement pathway. However, experiments with mycoplasmas and Escherichia coli indicated that the effect of MgEGTA was not identical for bovine and human sera. Sensitivity to killing by the alternative complement pathway in bovine serum appeared to be a property of avirulent strains and resistance to killing may be regarded as a virulence determinant of mycoplasmas.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7007210      PMCID: PMC1458144     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Interactions between Mycoplasma pneumoniae and guinea pig complement.

Authors:  W Bredt; D Bitter-Suermann
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

2.  Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

3.  Presence of a dialysable fraction in normal bovine whey capable of killing several species of bovine mycoplasmas.

Authors:  C J Howard; J Brownlie; R N Gourlay; J Collins
Journal:  J Hyg (Lond)       Date:  1975-04

4.  Pathogenicity of certain Mycoplasma species in the bovine mammary gland.

Authors:  J Brownlie; C J Howard; R N Gourlay
Journal:  Res Vet Sci       Date:  1976-05       Impact factor: 2.534

5.  Lysis and death of Mycoplasma pneumoniae by antibody and complement.

Authors:  H Brunner; S Razin; A R Kalica; R M Chanock
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

Review 6.  Comparative serology of domestic animals.

Authors:  C E Rice
Journal:  Adv Vet Sci       Date:  1968

7.  Role of complement in immune inactivation of Mycoplasma gallisepticum.

Authors:  L F Barker; J K Patt
Journal:  J Bacteriol       Date:  1967-08       Impact factor: 3.490

8.  Effect of complete and genetically defective mouse complement on Mycoplasma canis.

Authors:  D K Tachibana; L Hayflick; L T Rosenberg
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

9.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

10.  Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.

Authors:  R M Des Prez; C S Bryan; J Hawiger; D G Colley
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

View more
  3 in total

1.  Capsulelike surface material of Mycoplasma dispar induced by in vitro growth in culture with bovine cells is antigenically related to similar structures expressed in vivo.

Authors:  R A Almeida; R F Rosenbusch
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.

Authors:  P Rainard; C Boulard
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 3.  Mycoplasma bovis Mastitis.

Authors:  Aga E Gelgie; Mesula G Korsa; Oudessa Kerro Dego
Journal:  Curr Res Microb Sci       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.